Earliest predictors of language outcomes in high-risk infants
Earliest predictors of language outcomes in high-risk infants
批准号:
10357782
负责人:
Lisa Leigh Hunter
金额:
$65.67万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-01 至 2025-02-28
关键词:
3 year oldAgeAuditoryAuditory Evoked PotentialsBiological MarkersBirthBrainChildCochlear implant procedureCommunicationDemographic FactorsDetectionDevelopmentDiffuseDiffusion Magnetic Resonance ImagingEarly InterventionEarly identificationElectroencephalographyEnrollmentFrequenciesFunctional Magnetic Resonance ImagingFundingGestational AgeGoalsHearingHearing TestsHearing problemHigh-Frequency Hearing LossImpairmentInfantInterventionLanguageLanguage DisordersLanguage TherapyLifeLongitudinal cohortMagnetic Resonance ImagingMeasuresMethodsModelingNational Institute of Neurological Disorders and StrokeNeonatalNeurodevelopmental DisorderNeuronal PlasticityNewborn InfantNursery SchoolsOutcomeOutcome MeasurePerinatalPhysiologicalPremature BirthPremature InfantPrevalencePrognostic MarkerProspective StudiesRestRiskRisk FactorsSamplingScanningServicesSpeechSpeech DisordersStimulusSurvivorsTherapeutic Studieshearing impairmenthearing screeninghigh riskhigh risk infantimprovedinnovationlanguage outcomeliteracyneurodevelopmentnovelotoacoustic emissionpermanent hearing losspredictive modelingresponsescreeningspeech processingstudy populationwhite matter
中文摘要
在美国,每九个婴儿中就有一个早产。言语、语言和听力障碍
(SLD)是儿童最常见的神经发育障碍之一,尤其是
在早产幸存者中。约40%的极早产儿(≤32周胎龄)
当10%的人患有永久性听力损失时,会出现言语语言障碍,这会增加
对沟通困难的影响。目前,不可能在第一时间准确地预测
几年的生活中,孩子们会患上言语语言障碍,而言语-
语言治疗是为早产儿提供的所有干预措施中延迟最多的。这样的一种
先进的将促进早期干预和研究治疗期间的关键窗口
最佳神经可塑性。我们的中心假设是言语语言障碍的预测是
有可能在3米修正年龄(CA)之前,结合结构和
用磁共振成像、诱发反应测量大脑功能连接性
语音处理,以及新颖的敏感化听力措施。主要目标是(1)确定
预测SLD的早产儿脑连接缺陷的生物标志物;(2)确定
早产儿言语处理障碍和各种程度的听力损失;以及
利用先进的生物标记物开发早产儿不良言语的预测模型,
两年和三年CA的语言和识字前成绩。这项提案将提前入学。
在一项前瞻性研究中,婴儿将完成全面的语音-语言和前
在加州大学的2年和3年的识字评估。和36米CA。首要目标是开发一种
稳健的预测模型,使用创新措施,以实现早期识别儿童在
系统性红斑狼疮的高风险。
英文摘要
One in every nine babies in the US is born preterm. Speech, language and hearing disorders
(SLD) are among the most prevalent neurodevelopmental disorders in children, especially
among very preterm survivors. About 40% of very preterm infants (≤32 weeks gestational age)
develop speech-language disorders while 10% have permanent hearing loss, increasing the
impact on communication difficulties. Currently, it is not possible to accurately predict in the first
several years of life which children will develop speech-language disorders, and speech-
language therapy is the most delayed of any intervention provided to preterm infants. Such an
advance would facilitate early intervention and research therapies during critical windows of
optimal neuroplasticity. Our central hypothesis is that prediction of speech-language disorders is
possible by 3 m corrected age (CA) with combined innovative measures of structural and
functional brain connectivity with magnetic resonance imaging, evoked response measures of
speech processing, and novel, sensitized hearing measures. Primary aims are to (1) Identify
biomarkers of brain connectivity deficits in very preterm infants that predict SLD; (2) Identify
impaired speech processing and all degrees of hearing loss in very preterm infants; and (3)
Develop predictive models using advanced biomarkers in preterm infants for adverse speech,
language and pre-literacy outcomes at 2 and 3 years CA. This proposal will enroll very preterm
infants in a prospective study that will complete comprehensive speech-language and pre-
literacy assessments at 2 and 3 years CA. and 36 m CA. The overarching goal is to develop a
robust prediction model using innovative measures to enable early identification of children at
high risk for SLD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Earliest predictors of language outcomes in high-risk infants
-
批准号:10579249
-
项目类别:
-
资助金额:$63.82万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
Earliest predictors of language outcomes in high-risk infants
-
批准号:10116363
-
项目类别:
-
资助金额:$66.7万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
Supplement - Earliest Predictors of Language Outcomes in High-risk Infants
-
批准号:10513836
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
Earliest predictors of language outcomes in high-risk infants
-
批准号:10841986
-
项目类别:
-
资助金额:$45.31万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: